Home/Filings/4/0000899243-22-014088

4//SEC Filing

Ally Bridge MedAlpha Master Fund L.P. 4

Accession 0000899243-22-014088

CIK 0001402479other

View on SEC.gov Company Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:30 PM ET

Size

25.6 KB

Accession

0000899243-22-014088

Insider Transaction Report

Form 4

Period: 2022-04-04

MedAvail Holdings, Inc.MDVL

Ally Bridge MedAlpha Master Fund L.P.

10% Owner

Transactions

Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)

Ally Bridge Group (NY) LLC

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)

ABG-WTT Global Life Science Capital Partners GP, L.P.

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)

ABG-WTT Global Life Science Capital Partners GP Ltd

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)

ABG Management Ltd.

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)

Yu Fan

10% Owner

Transactions

Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)

ABG WTT-MedAvail Ltd

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)

Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.

10% Owner

Transactions

Purchase
Common Stock
2022-04-04$1.06/sh+11,143,529$11,840,000→ 15,029,480 total(indirect: See footnote)
Purchase
Common Stock
2022-04-04$1.06/sh+2,974,117$3,159,999→ 5,894,897 total(indirect: See footnote)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+1,487,058$1,579,999→ 1,487,058 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (1,487,058 underlying)
Purchase
Warrant (Right to Buy)
2022-04-04$1.06/sh+5,571,764$5,919,999→ 5,571,764 total(indirect: See footnote)
Exercise: $1.25From: 2022-04-04Exp: 2027-04-04→ Common Stock (5,571,764 underlying)

Footnotes (2)

[F1]These securities are held of record by ABG WTT-MedAvail Limited ("ABG WTT"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership.
[F2]These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. ("MedAlpha"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership. As a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MedAvail Holdings, Inc.

CIK 0001402479

→

Entity typeother

IncorporatedCayman Islands

Related Parties

filerCIK 0001831963

Filing Metadata

Form type: 4
Filed: Apr 5, 8:00 PM ET
Accepted: Apr 6, 4:30 PM ET
Size: 25.6 KB

View on SEC.gov